ClinVar Miner

Submissions for variant NM_000059.3(BRCA2):c.4718G>A (p.Cys1573Tyr) (rs56249050)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 10
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV001081098 SCV000072489 likely benign Hereditary breast and ovarian cancer syndrome 2020-12-03 criteria provided, single submitter clinical testing
Ambry Genetics RCV000132250 SCV000187333 likely benign Hereditary cancer-predisposing syndrome 2018-11-14 criteria provided, single submitter clinical testing In silico models in agreement (benign);Other data supporting benign classification
GeneDx RCV000758898 SCV000518764 likely benign not provided 2021-03-09 criteria provided, single submitter clinical testing This variant is associated with the following publications: (PMID: 20609467, 10699917)
Color Health, Inc RCV000132250 SCV000683648 likely benign Hereditary cancer-predisposing syndrome 2015-03-11 criteria provided, single submitter clinical testing
Counsyl RCV000077337 SCV000786380 uncertain significance Breast-ovarian cancer, familial 2 2018-04-27 criteria provided, single submitter clinical testing
Quest Diagnostics Nichols Institute San Juan Capistrano RCV000758898 SCV000887823 likely benign not provided 2019-10-09 criteria provided, single submitter clinical testing
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV000445221 SCV000918863 uncertain significance not specified 2019-11-08 criteria provided, single submitter clinical testing Variant summary: BRCA2 c.4718G>A (p.Cys1573Tyr) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 8e-06 in 251100 control chromosomes (gnomAD). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.4718G>A has been reported in the literature in individuals affected with Hereditary Breast and Ovarian Cancer (Spitzer_2000, Tutt_2010, He_2016). A co-occurrence with another pathogenic BRCA1 variant, c.1687C>T (p.Q563X) has been reported, providing supporting evidence for a benign role. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Six ClinVar submissions (evaluation after 2014) cites the variant 5 times as likely benign and once as uncertain significance. Based on the evidence outlined above, the variant was classified as VUS-possibly benign.
Research and Development, ARUP Laboratories RCV001646302 SCV001854806 likely benign Breast-ovarian cancer, familial 2; Breast-ovarian cancer, familial 1; Hereditary breast and ovarian cancer syndrome 2020-01-20 criteria provided, single submitter curation
Sharing Clinical Reports Project (SCRP) RCV000077337 SCV000109134 benign Breast-ovarian cancer, familial 2 2012-03-12 no assertion criteria provided clinical testing
Breast Cancer Information Core (BIC) (BRCA2) RCV000077337 SCV000146474 uncertain significance Breast-ovarian cancer, familial 2 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.